-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Areas/Patient_Safety
patients with an anticoagulant-related adverse drug event to low-molecular-weight heparin (LMWH) and factor
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Setting_of_Care/Hospital
February 17, 2021 - patients with an anticoagulant-related adverse drug event to low-molecular-weight heparin (LMWH) and factor
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Areas/Patient_Safety
patients with an anticoagulant-related adverse drug event to low-molecular-weight heparin (LMWH) and factor
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Type_of_Care/Acute_Care
February 17, 2021 - patients with an anticoagulant-related adverse drug event to low-molecular-weight heparin (LMWH) and factor
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Setting_of_Care/Hospital
February 19, 2021 - patients with an anticoagulant-related adverse drug event to low-molecular-weight heparin (LMWH) and factor
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/summary/All_Measures/All_Topics
Home
National View
National Quality Measures Compared to Achievable Benchmarks
The quality measures are compared to achievable benchmarks, which are derived from the top-performing States. Better performance of a State can mean higher or lower values of a measure, depending on the desired outcome. For ex…
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Type_of_Care/Acute_Care
February 19, 2021 - patients with an anticoagulant-related adverse drug event to low-molecular-weight heparin (LMWH) and factor
-
nhqrnet.ahrq.gov/inhqrdr/reports/related
March 01, 2014 - National Quality Strategy Reports
2011 National Quality Strategy Report - The initial National Quality Strategy, published in March 2011, established three aims and six priorities for quality improvement.
2012 National Quality Strategy Report - The National Quality Strategy's first annual progress report to Con…
-
nhqrnet.ahrq.gov/inhqrdr/resources/info
December 01, 2020 - Resources for Addressing Disparities and Improving Quality
Last Updated: December 2020
Overview
Quality health care means delivering services in ways that are safe, timely, patient centered, effective, efficient, and equitable. Unfortunately, our health care system often distributes services inefficiently and une…
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Elderly_Adults
patients with an anticoagulant-related adverse drug event to low-molecular-weight heparin (LMWH) and factor
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Older_Adults
patients with an anticoagulant-related adverse drug event to low-molecular-weight heparin (LMWH) and factor
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Non-Hispanic_White
February 19, 2021 - patients with an anticoagulant-related adverse drug event to low-molecular-weight heparin (LMWH) and factor
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Women
February 19, 2021 - patients with an anticoagulant-related adverse drug event to low-molecular-weight heparin (LMWH) and factor
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Male
patients with an anticoagulant-related adverse drug event to low-molecular-weight heparin (LMWH) and factor
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Female
patients with an anticoagulant-related adverse drug event to low-molecular-weight heparin (LMWH) and factor
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Elderly_Adults
patients with an anticoagulant-related adverse drug event to low-molecular-weight heparin (LMWH) and factor
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/Black
February 19, 2021 - patients with an anticoagulant-related adverse drug event to low-molecular-weight heparin (LMWH) and factor
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/All_Measures/All_Topics
February 19, 2021 - patients with an anticoagulant-related adverse drug event to low-molecular-weight heparin (LMWH) and factor
-
nhqrnet.ahrq.gov/inhqrdr/National/trend/table/Priority_Populations/White
February 19, 2021 - patients with an anticoagulant-related adverse drug event to low-molecular-weight heparin (LMWH) and factor
-
nhqrnet.ahrq.gov/inhqrdr/National/benchmark/table/Priority_Populations/Women
February 19, 2021 - patients with an anticoagulant-related adverse drug event to low-molecular-weight heparin (LMWH) and factor